Processa Pharmaceuticals, Inc.
PCSA
$1.99
-$0.17-7.87%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.31% | -0.54% | 2.26% | 12.64% | -38.79% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 554.36% | 190.79% | -152.41% | 44.42% | -9.57% |
| Change in Net Operating Assets | 167.61% | -158.69% | 267.70% | -126.14% | 1,081.22% |
| Cash from Operations | 44.41% | -23.79% | 16.75% | -53.47% | 16.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 137.20% | 41.18% | -- | -- | -- |
| Cash from Investing | 137.20% | 41.18% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -192.31% | 13.33% |
| Issuance of Common Stock | 28.60% | -91.77% | 4.17% | -54.75% | 42.39% |
| Repurchase of Common Stock | 100.00% | -- | -- | 100.00% | -542.86% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 28.76% | -91.78% | 4.30% | -54.74% | 42.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.14% | -398.50% | -22.81% | -115.55% | 136.82% |